(19)
(11) EP 3 122 417 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.12.2023 Bulletin 2023/52

(45) Mention of the grant of the patent:
22.11.2023 Bulletin 2023/47

(21) Application number: 15712014.8

(22) Date of filing: 12.03.2015
(51) International Patent Classification (IPC): 
A61N 1/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/36114; A61N 1/36139; A61N 1/3615
(86) International application number:
PCT/US2015/020116
(87) International publication number:
WO 2015/148142 (01.10.2015 Gazette 2015/39)

(54)

RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION

REAKTIVE NERVENSTIMULATION ZUR BEHANDLUNG VON CHRONISCHER KARDIALER DYSFUNKTION

NEUROSTIMULATION SENSIBLE POUR LE TRAITEMENT D'UN DYSFONCTIONNEMENT CARDIAQUE CHRONIQUE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 25.03.2014 US 201414224922
17.04.2014 US 201414255276
25.04.2014 US 201414262270
25.04.2014 US 201414262289
07.05.2014 US 201414271714

(43) Date of publication of application:
01.02.2017 Bulletin 2017/05

(73) Proprietors:
  • LivaNova USA, Inc.
    Houston, TX 77058 (US)
  • East Tennessee State University
    Johnson City, TN 37614 (US)

(72) Inventors:
  • KENKNIGHT, Bruce H.
    Houston, Texas 77058 (US)
  • LIBBUS, Imad
    Houston, Texas 77058 (US)
  • AMURTHUR, Badri
    Houston, Texas 77058 (US)
  • ARDELL, Jeffrey L.
    Johnson City, Tennessee 37614 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)


(56) References cited: : 
WO-A1-2010/005482
US-A1- 2005 267 542
 WO-A1-2013/086170
US-A1- 2010 114 227
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).